ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

Consensus Conference In Early Breast Cancer Planned For June

May 11, 1990

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979

Radiation Dose Reconstruction Methods For Compensation Cases In Final Rule By HHS.

May 17, 2002

In Brief: Congress Sets NCI Rescission At $10.785 Million; Centers to Be Funded According To Priority Scores

June 12, 1981

Screening Frequency for Cervical Cancer May Be Reduced, ACS Says

November 22, 2002

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009